ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

WHT Participants Get “Phase Out” Help

March 11, 1988

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

Nominations sought for NCI consumer liaison group.

January 9, 2004

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013